Seaford Pharmaceuticals awarded Canadian Distributor Rights

 

Seaford Pharmaceuticals awarded Canadian distributor rights for Indocyanine Green following Health Canada approval:

Farmington Hills, MI, USA, 10th June 2019, DIAGNOSTIC GREEN LLC (Diagnostic Green), the leading provider of trusted high quality fluorescence agents has announced that SEAFORD PHARMACEUTICALS INC. (Seaford Pharmaceuticals) has acquired exclusive distribution rights for Indocyanine Green for the region of Canada.

Founded in 1991 by the Seales family, Seaford Pharmaceuticals, headquartered in Ontario, researches, develops and markets specialty healthcare solutions in Canada and internationally.  Seaford Pharmaceuticals offers unique, quality products in many therapeutic areas including specialty products such as medical diagnostics with the launch of Indocyanine Green.

“We are very much looking forward to working with Seaford as they bring Indocyanine Green to market throughout the region of Canada, following Indocyanine Green approval by Health Canada” stated Ron Clarke, VP Business Development at Diagnostic Green.  

Indocyanine Green is well known and accepted by physicians worldwide with over 11,000 published on use and applications (PubMed).  Indicated for use in determining cardiac output, hepatic function and liver blood flow and for ophthalmic angiography, Indocyanine Green is well tolerated, with an excellent safety profile.  It is routinely used by physicians as a fluorescence perfusion diagnostic.  For full prescribing details, contact Seaford Pharmaceuticals. 

For further information contact:

Diagnostic Green, LLC 38955 Hills Tech Drive Farmington Hills MI 48331 United States, +1-844-ICG-VIAL (424-8425), info@diagnosticgreen.com.

Seaford Pharmaceuticals Inc., 28 – 1530 Drew Road, Mississauga, ON, L5S 1W8 Canada, +1 (888) 292-3192, info@seaford.ca

*https://www.ncbi.nlm.nih.gov/pubmed/?term=indocyanine+green

Communiqué

Seaford Pharmaceuticals obtient les droits de distribution canadienne pour le vert d’indocyanine à la suite de l’approbation du produit par Santé Canada :

Farmington Hills, MI, É.-U., 10 juin 2019, DIAGNOSTIC GREEN LLC (Diagnostic Green), principal fournisseur d’agents fluorescents de qualité supérieure a annoncé que SEAFORD PHARMACEUTICALS INC. (Seaford Pharmaceuticals) a acquis les droits exclusifs de distribution du vert d’indocyanine pour le Canada.

Fondé en 1991 par la famille Seales, Seaford Pharmaceuticals – dont le siège social se trouve en Ontario – se consacre à la recherche, au développement et à la commercialisation de solutions de soins de santé spécialisées au Canada et à l’étranger.  Seaford Pharmaceuticals offre des produits de qualité uniques dans de nombreux domaines thérapeutiques, y compris les produits spécialisés comme les diagnostics médicaux avec le lancement du vert d’indocyanine.

« Nous nous réjouissons à l’idée de travailler avec Seaford au moment où elle met en marché le vert d’indocyanine dans tout le Canada à la suite de son approbation par Santé Canada » a déclaré Ron Clarke, vice-président, Développement des affaires, chez Diagnostic Green.  

Le vert d’indocyanine est bien connu et accepté par les médecins dans le monde entier avec plus de 11 000 études publiées sur son utilisation et ses applications (PubMed). Indiqué pour évaluer le débit cardiaque, la fonction hépatique, le débit sanguin hépatique ainsi que pour l’angiographie ophtalmique, le vert d’indocyanine est bien toléré comme en témoigne son excellent profil d’innocuité. Les médecins utilisent couramment la fluorescence par injection de vert d’indocyanine pour effectuer des tests diagnostiques. Pour obtenir de l’information complète sur la posologie, veuillez contacter Seaford Pharmaceuticals. 

Pour de plus amples renseignements :

Diagnostic Green, LLC 38955 Hills Tech Drive Farmington Hills MI 48331 États-Unis, +1-844-ICG-VIAL (424-8425), info@diagnosticgreen.com.

Seaford Pharmaceuticals Inc., 28 – 1530 Drew Road, Mississauga, ON, L5S 1W8 Canada, +1 (888) 292-3192, info@seaford.ca

*https://www.ncbi.nlm.nih.gov/pubmed/?term=indocyanine+green

 

 

Diagnostic Green attend Barcelona Breast Meeting 2019

Diagnostic Green were pleased to attend this years BBM Barcelona Breast Meeting and the International Breast Cancer Coordinated Care Conference (IBC4) held in Hospital de Sant Pau, Barcelona on March 12th – 15th, 2019.

The BBM is atended by world leaders in aesthetic, oncoplastic and reconstructive breast surgery over 4 days.

This year Diagnostic Green had the honor of speakers Dr. Bianca Baican, Dr. Sinnikka Suominen and Dr. Gemma Pons speaking on the use of IC-Flow™ Imaging System at an afternoon symposium on 13th March titled, “ICG Imaging in Breast Surgery: make your surgery more efficient”.

More information on the Barcelona Breast Meeting can be found here

Vistamerica Announced as Distributor for ICG in Mexico

Farmington Hills, MI, USA, 4th March 2019, DIAGNOSTIC GREEN LLC (Diagnostic Green), the leading provider of trusted high quality fluorescence agents, has announced that VISTAMERICA S de RL (Vistamerica) has won exclusive distribution rights for Indocyanine Green (ICG), for the territory of Mexico.

“We are delighted to engage with such a dedicated and enthusiastic company that will ensure ICG will be available to physicians throughout Mexico”, stated Ron Clarke, VP Business Development at Diagnostic Green. 

Founded in 2009 by Ophthalmologist, Dr Scott Markham, and Catalina Markham,  Vistamerica is a young company that prides itself in understanding the needs of both patients and doctors seeking to offer excellent service and quality in their products.  It specializes in distributing high quality ophthalmic medical products and devices.

ICG is well known and accepted by physicians worldwide with over 11,000 published on use and applications (pubmed*).  Indicated for use in determining cardiac output, hepatic function and liver blood flow and for ophthalmic angiography, ICG is well tolerated, with an excellent safety profile.  It is routinely used by physicians as a fluorescence perfusion diagnostic.  For full prescribing details, contact Vistamerica. 

For further information contact:

Diagnostic Green, LLC 38955 Hills Tech Drive Farmington Hills MI 48331 United States, 1-844-ICG-VIAL (424-8425), info@diagnosticgreen.com.

Vistamerica S de RL , Sinaloa Avenue No. 183-3, South Center, 83550, Puerto Peñasco, Sonora, Mexico.  Office: + 52-638-38-88668, Info@vistamerica.net.

*https://www.ncbi.nlm.nih.gov/pubmed/?term=indocyanine+green